Physician profile
Jonathan Waxman
NPI 1194761973
$15,395.86
in general payments reported to CMS, 2019-2025
17 companies · $1,236 in 2025
The $1,236 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $200 · 2021: $517 · 2022: $304 · 2023: $5,560 · 2024: $6,810 · 2025: $1,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Consulting Fee: $4,681 · Food and Beverage: $2,005 · Travel and Lodging: $1,405 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Consulting Fee | $4,680.89 |
| Food and Beverage | $2,004.53 |
| Travel and Lodging | $1,405.39 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,622.79 | 2019-2025 | |
| Medical Device Business Services, INC. | $5,438.89 | 2023 | Monarch |
| On Target Laboratories, INC | $638.73 | 2025 | Cytalux |
| Atricure, INC. | $484.33 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Ethicon INC. | $364.76 | 2020-2021 | |
| Lilly USA, LLC | $246.40 | 2022 | |
| Ethicon US, LLC | $111.29 | 2021-2024 | Echelon Endopath |
| Veran Medical Technologies, INC. | $89.00 | 2019-2020 | |
| Pinnacle Biologics, INC | $84.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $63.54 | 2023-2024 | |
| Karl Storz Endoscopy-America | $61.77 | 2021 | |
| Boston Scientific Corporation | $45.51 | 2023 | Spyglass |
| Davol INC. | $44.16 | 2024-2025 | Progel Applicator Spray Tips |
| Merck Sharp & Dohme LLC | $42.27 | 2024-2025 | Keytruda |
| Tela Bio, INC. | $22.89 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $18.84 | 2022 | |
| Penumbra, INC. | $16.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Waxman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.